Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease

International Journal of Infectious Diseases

Volumn 14, Issue 5, 2010, Pages

  Méndez Samperio, Patricia ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Infection; Interleukin 12; Interleukin 23; Interleukin 27; Mycobacteria

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 23; INTERLEUKIN 27; BCG VACCINE;

ADAPTIVE IMMUNITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MYCOBACTERIOSIS; PROTEIN FUNCTION; REVIEW; TH17 CELL; ANTIGEN PRESENTATION; CD4+ T LYMPHOCYTE; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; INTERLEUKIN-12; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 77955862167     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.06.022     Document Type: Review

References (94)

1. Global tuberculosis control: surveillance, planning, financing 2008, World Health Organization, World Health Organization, Geneva.
2. Gandhi N.R., Moll A., Sturm A.W., Pawinski R., Govender T., Lalloo U., et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006, 368:1575-1580.
3. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994, 271:698-702.
4. Trunz B.B., Fine P., Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost- effectiveness. Lancet 2006, 367:1173-1180.
5. Flynn J.L., Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001, 19:93-129.
6. Giacomini E., Iona E., Ferroni L., Miettinen M., Fattorini L., Orefici G., et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001, 166:7033-7041.
7. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989, 170:827-845.
8. Gately M.K., Desai B.B., Wolitzky A.G., Quinn P.M., Dwyer C.M., Podlaski F.J., et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1991, 147:874-882.
9. Hunter C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005, 5:521-531.
10. Beadling C., Slifka M.K. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch Immunol Ther Exp 2006, 54:15-24.
11. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
12. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
13. Kang B.Y., Kim T.S. Targeting cytokines of the interleukin-12 family in autoimmunity. Curr Med Chem 2006, 13:1149-1156.
14. D'Andrea A., Rengaraju M., Valiante N.M., Chehimi J., Kubin M., Aste M., et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992, 176:1387-1398.
15. Boulay J.L., O'Shea J.J., Paul W.E. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 2003, 19:159-163.
16. Trinchieri G., Pflanz S., Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of Tcell responses. Immunity 2003, 19:641-644.
17. Nagayama H., Sato K., Kawasaki H., Enomoto M., Morimoto C., Tadokoro K., et al. IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells. J Immunol 2000, 165:59-66.
18. Batten M., Ghilardi N. The biology and therapeutic potential of interleukin 27. J Mol Med 2007, 85:661-672.
19. Gerosa F., Paganin C., Peritt D., Paiola F., Scupoli M.T., Aste-Amezaga M., et al. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon gamma and interleukin-10. J Exp Med 1996, 183:2559-2569.
20. Chan S.H., Perussia B., Gupta J.W., Kobayashi M., Pospísil M., Young H.A., et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991, 173:869-879.
21. Filipe-Santos O., Bustamante J., Chapgier A. Vogt G, de Beaucoudrey L, Feinberg J, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006, 18:347-361.
22. Metzger D.W., McNutt R.M., Collins J.T., Buchanan J.M., Van Cleave V.H., Dunnick W.A. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma- dependent and -independent mechanisms. Eur J Immunol 1997, 27:1958-1965.
23. Curtsinger J.M., Lins D.C., Mescher M.F. Signal 3 determines tolerance versus full activation of naïve CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 2003, 197:1141-1151.
24. Yoo J.K., Cho J.H., Lee S.W., Sung Y.C. IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase/Akt signaling pathway. J Immunol 2002, 169:3637-3643.
25. Ling P., Gately M.K., Gubler U., Stern A.S., Lin P., Hollfelder K., et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 1995, 154:116-127.
26. Gately M.K., Carvajal D.M., Connaughton S.E., Gillessen S., Warrier R.R., Kolinsky K.D., et al. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann N Y Acad Sci 1996, 795:1-12.
27. Shimozato O., Ugai S., Chiyo M., Takenobu H., Nagakawa H., Wada A., et al. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology 2006, 117:22-28.
28. Abdi K. IL-12: the role of p40 versus p75. Scand J Immunol 2002, 56:1-11.
29. Ha S.J., Lee C.H., Lee S.B., Kim C.M., Jang K.L., Shin H.S., et al. A novel function of IL-12p40 as a chemotactic molecule for macrophages. J Immunol 1999, 163:2902-2908.
30. Khader S., Partida-Sanchez S., Bell G., Jelley-Gibbs D., Swain S., Pearl J., et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med 2006, 203:1805-1815.
31. Henry C.J., Ornelles D.A., Mitchell L.M., Brzoza-Lewis K.L., Hiltbold E.M. IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol 2008, 181:8576-8584.
32. Méndez-Samperio P., Ayala-Verdin H.E., Trejo-Echeverria A. Interleukin-12 regulates the production of bacille Calmette-Guérin-induced interferon-gamma from human cells in a CD40-dependent manner. Scand J Immunol 1999, 50:61-67.
33. Schulz O., Edwards A.D., Schito M., Aliberti J., Manickasingham S., Sher A., et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000, 13:453-462.
34. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., Lanzavecchia A. Selected toll-like receptor agonist combinations synergistically trigger a T helper type-1-polarizing program in dendritic cells. Nat Immunol 2005, 6:769-776.
35. Scanga C., Bafica A., Feng C., Cheever A., Hieny S., Sher A. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect Immun 2004, 72:2400-2404.
36. Wirtz S., Becker C., Fantini M.C., Nieuwenhuis E.E., Tubbe I., Galle P.R., et al. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J Immunol 2005, 174:2814-2824.
37. Bafica A., Scanga C., Feng C., Leifer C., Cheever A., Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005, 202:1715-1724.
38. Pecora N., Gehring A., Canaday D., Boom W., Harding C. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol 2006, 177:422-429.
39. Re F., Strominger J. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001, 276:37692-37699.
40. Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002, 168:5699-5708.
41. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
42. Ghilardi N., Kljavin N., Chen Q., Lucas S., Gurney A.L., de Sauvage F.J. Compromised humoral and delayed-type hypersensitivity responses in IL-23 deficient mice. J Immunol 2004, 172:2827-2833.
43. Langrish C., Chen Y., Blumenschein W., Mattson J., Basham B., Sedgwick J., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
44. Harrington L.E., Mangan P.R., Weaver C.T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006, 18:349-356.
45. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852.
46. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
47. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
48. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
49. Ivanov I., Zhou L., Littman D. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007, 19:409-417.
50. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
51. Kastelein R.A., Hunter C.A., Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007, 25:221-242.
52. Villarino A.V., Larkin J., 3rd, Saris C.J., Caton A.J., Lucas S., Wong T., et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol 2005, 174:7684-7691.
53. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006, 7:937-945.
54. Neufert C., Becker C., Wirtz S., Fantini M.C., Weigmann B., Galle P.R., et al. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol 2007, 37:1809-1816.
55. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003, 170:4886-4890.
56. Stumhofer J.S., Hunter C.A. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008, 117:123-130.
57. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006, 7:929-936.
58. Villarino A.V., Stumhofer J.S., Saris C.J., Kastelein R.A., de Sauvage F.J., Hunter C.A. IL-27 limits IL-2 production during Th1 differentiation. J Immunol 2006, 176:237-247.
59. Wirtz S., Tubbe I., Galle P.R., Schild H.J., Birkenbach M., Blumberg R.S., et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 2006, 203:1875-1881.
60. Lucas S., Ghilardi N., Li J., de Sauvage F.J. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 2003, 100:15047-15052.
61. Hibbert L., Pflanz S., de Waal M.R., Kastelein R.A. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 2003, 23:513-522.
62. Yoshida H., Hamano S., Miyazaki Y. The double identity of WSX-1 (IL-27R) as an initiator and attenuator of immune responses. Curr Immunol Rev 2005, 1:55-60.
63. Yoshimura T., Takeda A., Hamano S., Miyazaki Y., Kinjyo I., Ishibashi T., et al. Two-sided roles of IL-27: induction of Th1 differentiation on naïve CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 2006, 177:5377-5385.
64. Villarino A., Hibbert L., Lieberman L., Wilson E., Mak T., Yoshida H., et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003, 19:645-655.
65. Miyazaki Y., Shimanoe Y., Wang S., Yoshida H. Amelioration of delayed-type hypersensitivity responses by IL-27 administration. Biochem Biophys Res Commun 2008, 373:397-402.
66. Neurath M.F. IL-12 family members in experimental colitis. Mucosal Immunol 2008, 1:S28-30.
67. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
68. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007, 37:3021-3029.
69. Brombacher F., Dorfmüller A., Magram J., Dai W.J., Köhler G., Wunderlin A., et al. IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int Immunol 1999, 11:325-332.
70. Cooper A.M., Kipnis A., Turner J., Magram J., Ferrante J., Orme I.M. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 2002, 168:1322-1327.
71. Chackerian A., Chen S., Brodie S., Mattson J., McClanahan T., Kastelein R., et al. Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection. Infect Immun 2006, 74:6092-6099.
72. Reinhardt R.L., Hong S., Kang S.J., Wang Z.E., Locksley R.M. Visualization of IL- 12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J Immunol 2006, 177:1618-1627.
73. Holscher C., Atkinson R., Arendse B., Brown N., Myburgh E., Alber G., et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol 2001, 167:6957-6966.
74. Khader S.A., Pearl J.E., Sakamoto K., Gilmartin L., Bell G.K., Jelley-Gibbs D.M., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J Immunol 2005, 175:788-795.
75. Feng C., Jankovic D., Kullberg M., Cheever A., Scanga C., Hieny S., et al. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J Immunol 2005, 174:4185-4192.
76. Khader S., Bell G., Pearl J., Fountain J., Rangel-Moreno J., Cilley G., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-377.
77. Feinberg J., Fieschi C., Doffinger R., Feinberg M., Leclerc T., Boisson-Dupuis S., et al. Bacillus Calmette-Guérin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol 2004, 34:3276-3284.
78. Filipe-Santos O., Bustamante J., Haverkamp M., Vinolo E., Ku C., Puel A., et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 2006, 203:1745-1759.
79. Cruz A., Khader S., Torrado E., Fraga A., Pearl J., Pedrosa J., et al. CE:IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006, 177:1416-1420.
80. Happel K.I., Lockhart E.A., Mason C.M., Porretta E., Keoshkerian E., Odden A.R., et al. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect Immun 2005, 73:5782-5788.
81. Veldhoen M., Hocking R., Flavell R., Stockinger B. Signals mediated by transforming growth factor beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 2006, 7:1151-1156.
82. Umemura M., Yahagi A., Hamada S., Begum M., Watanabe H., Kawakami K., et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guérin infection. J Immunol 2007, 178:3786-3796.
83. Khader S., Cooper A. IL-23 and IL-17 in tuberculosis. Cytokine 2008, 41:79-83.
84. Wozniak T., Ryan A., Britton W. Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J Immunol 2006, 177:8684-8692.
85. Wozniak T., Ryan A., Triccas J., Britton W. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect Immun 2006, 74:557-565.
86. Li H., Li R., Zhong S., Ren H., Zou Y., Chen X., et al. The immunogenicity and protective efficacy of Mtb8, 4/hIL-12 chimeric gene vaccine. Vaccine 2006, 24:1315-1323.
87. Yoshida S., Tanaka T., Kita Y., Kuwayama S., Kanamaru N., Muraki Y., et al. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation. Vaccine 2006, 24:1191-1204.
88. Okada M., Kita Y., Nakajima T., Kanamaru N., Hashimoto S., Nagasawa T., et al. Evaluation of a novel vaccine (HVJ- liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB. Vaccine 2007, 25:2990-2993.
89. Ha S., Park S., Kim H., Kim S., Kang H., Lee E., et al. Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination. Infect Immun 2006, 74:4954-4959.
90. Pearl J.E., Shabaana A.K., Solache A., Gilmartin L., Ghilardi N., deSauvage F., et al. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immunol 2004, 173:7490-7496.
91. Holscher C., Holscher A., Ruckerl D., Yoshimoto T., Yoshida H., Mak T., et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 2005, 174:3534-3544.
92. Scott-Browne J.P., Shafiani S., Tucker-Heard G., Ishida-Tsubota K., Fontenot J.D., Rudensky A.Y., et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 2007, 204:2159-2169.
93. Lockhart E., Green A., Flynn J. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006, 177:4662-4669.
94. D'Souza C.D., Cooper A.M., Frank A.A., Mazzaccaro R.J., Bloom B.R., Orme I.M. An anti- inflammatory role for γδ T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 1997, 158:1217-1221.